InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by PAKIANATHAN DEEPIKA, Director. Director active across 3 companies, notably Pardes Biosciences, INC.. Cumulatively, 6 disclosures have been recorded. Total volume traded: €2m. The latest transaction was filed on 8 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€2m322,825 shares@ €6.06781.13% mcap100.0% of flow
Common Stock
SEC:0000899243-22-021957:0·
09,852 shares0
Ordinary Shares
SEC:0001415889-22-004336:0·
030,000 shares0
Class A Common Stock
SEC:0001213900-21-068105·
030,000 shares0
Class A Common Stock
SEC:0001213900-21-068105:0·
052,500 shares0
Class A Common Stock
SEC:0001213900-21-067726·
052,500 shares0
Class A Common Stock
SEC:0001213900-21-067726:0·
6 of 6 declarations
About PAKIANATHAN DEEPIKA
Deepika Pakianathan serves as a Board Member at PARDES BIOSCIENCES, INC., Theravance Biopharma, Inc., and Karyopharm Therapeutics Inc. She brings expertise in strategy and innovation. In her role, she contributes to the strategic direction and oversight of the companies' operations.
